Friday, Glenmark Generics, a subsidiary of Glenmark Pharmaceuticals got ANDA approval from US FDA for Trandolapril tablets USP of 1 mg, 2 mg and 4 mg strengths. The company said that it would commence marketing and distribution of these products in US market immediately.
Trandolapril is an angiotensin-converting enzyme used to treat high blood pressure and is generic equivalent of Mavik tablets marketed by Abbott Laboratories. Total sales for Trandolapril tablets exceed $23 million in the twelve months period ending March 2008 as per IMS data.
(source: www.rttnews.com)
No comments:
Post a Comment